Preston C. Sprenkle, MD

Integration of prostate imaging and genomics for more personalized diagnosis and treatment of prostate cancers. collaborate with translational scientists and machine learning specialists to develop predictive models utilizing multiple clinical factors to improve diagnostic predictions and modeling.

Improving accuracy of prostate cancer diagnosis, staging, and treatment through enhanced imaging techniques with Prostate MRI and targeted prostate biopsies using our clinical outcomes database.

Clinical trial interventions on patients with high risk prostate cancer as well as utilizing new techniques and technologies for ablation (destruction) of prostate cancer using such technologies as cryoablation, irreversible electroporation, TULSA, laser ablation, and others.